Copyright
©The Author(s) 2022.
World J Clin Cases. Jun 6, 2022; 10(16): 5387-5393
Published online Jun 6, 2022. doi: 10.12998/wjcc.v10.i16.5387
Published online Jun 6, 2022. doi: 10.12998/wjcc.v10.i16.5387
Table 1 Results of laboratory tests performed at our hospital
Index | Result | Reference range | |
Blood count | White blood cell count (109/L) | 7.23 | 3.6-9.7 |
Hemoglobin (g/L) | 120 | 110-146 | |
Platelet count (109/L) | 379 | 100-450 | |
Urinary chemistry | Urinary protein (g/24 h) | 2.51 | 0-0.15 |
Urinary protein | 4+ | Negative | |
Urinary red blood cell count (cells/HP) | 4+ | 0-3 | |
Urinary leukocyte count (cells/HP) | 4+ | 0-5 | |
Pathological casts | Positive | Negative | |
Serum chemistry | Albumin (g/L) | 20 | 35-50 |
Total cholesterol (mmol/L) | 6.29 | < 5.18 | |
Triglyceride (mmol/L) | 1.38 | < 1.7 | |
Blood urea nitrogen (mmol/L) | 4.76 | 3.2-7.1 | |
Serum creatinine (μmol/L) | 35 | 17.3-54.6 | |
Immunology | Immunoglobulin G (g/L) | 2.21 | 5.29-21.9 |
Immunoglobulin A (g/L) | 0.39 | 0.41-3.95 | |
Immunoglobulin M (g/L) | 0.96 | 0.48-2.26 | |
Immunoglobulin E (g/L) | 17.2 | < 90 | |
Complement C3 (g/L) | 0.98 | 0.7-2.06 | |
Complement C4 (g/L) | 0.18 | 0.11-0.61 | |
Complement C1q (mg/dL) | 23.9 | 15.7-23.7 |
Table 2 Results of urinalysis during follow-up
Time of follow-up (d) | Urinary proteinuria | Urinary RBC count (cells/μL) | Urinary WBC count (cells/μL) | Urinary pathologic casts (cells/μL) |
0 | 4+ | 1066 | 98 | 14 |
16 | 2+ | 280 | 9 | 0 |
60 | 3+ | 325 | 34 | 0 |
77 | 3+ | 1689 | 91.9 | 4.81 |
118 | 3+ | 1286 | 14 | 0 |
130 | Negative | 53 | 3 | 0 |
144 | Negative | 59 | 10 | 0 |
Table 3 Differences between idiopathic membranous nephropathy and minimal change disease in children
IMN | MCD | ||
General features | Sex | Male | Male |
Age | Adolescence | Preschool age | |
Clinical manifestations | Nephrotic syndrome | Common | Common |
Leukocyturia | Some | Rare | |
Hematuria | Some | Rare | |
Hypertension | Some | Rare | |
Renal failure | Some | Rare | |
Laboratory tests | Anti-PLA2R, antibody | Elevated | Normal |
Anti-THSD7A, antibody | Elevated | Normal | |
Treatment strategy | Prednisone | Mostly resistance | Mostly sensitive |
Immunosuppressant | Tacrolimus, cyclophosphamide, mycophenolate mofetil | Rare | |
Biological agent | Rituximab | Rare |
- Citation: Cui KH, Zhang H, Tao YH. Idiopathic membranous nephropathy in children: A case report. World J Clin Cases 2022; 10(16): 5387-5393
- URL: https://www.wjgnet.com/2307-8960/full/v10/i16/5387.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i16.5387